Matthew David ALEXANDER

Person

Boston, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Cereblon binding compounds, compositions thereof, and methods of tr...
- Patent number 12,103,920
- Issue date Oct 1, 2024
- Celgene Corporation
- Matthew D. Alexander
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antiproliferative compounds and methods of use thereof
- Patent number 12,029,738
- Issue date Jul 9, 2024
- Celgene Corporation
- Matthew D. Alexander
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted 4-aminoisoindoline-1,3-dione compounds, compositions th...
- Patent number 11,945,804
- Issue date Apr 2, 2024
- Celgene Corporation
- Matthew D. Alexander
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cereblon binding compounds, compositions thereof, and methods of tr...
- Patent number 11,739,075
- Issue date Aug 29, 2023
- Celgene Corporation
- Matthew D. Alexander
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cereblon binding compounds, compositions thereof, and methods of tr...
- Patent number 11,634,407
- Issue date Apr 25, 2023
- Celgene Corporation
- Matthew D. Alexander
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted aminopurine compounds, compositions thereof, and method...
- Patent number 11,590,139
- Issue date Feb 28, 2023
- Signal Pharmaceuticals, LLC
- Matthew Alexander
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
MK2 inhibitors and uses thereof
- Patent number 11,584,757
- Issue date Feb 21, 2023
- Celgene CAR LLC
- Matthew David Alexander
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cereblon binding compounds, compositions thereof, and methods of tr...
- Patent number 11,560,371
- Issue date Jan 24, 2023
- Celgene Corporation
- Matthew D. Alexander
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antiproliferative compounds, and their pharmaceutical compositions...
- Patent number 11,365,184
- Issue date Jun 21, 2022
- Celgene Corporation
- Matthew D. Alexander
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted 4-aminoisoindoline-1,3-dione compounds, compositions th...
- Patent number 11,358,952
- Issue date Jun 14, 2022
- Celgene Corporation
- Matthew D. Alexander
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antiproliferative compounds and methods of use thereof
- Patent number 11,185,543
- Issue date Nov 30, 2021
- Celgene Corporation
- Matthew D. Alexander
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
MK2 inhibitors and uses thereof
- Patent number 11,098,061
- Issue date Aug 24, 2021
- Celgene CAR LLC
- Matthew David Alexander
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted aminopurine compounds, compositions thereof, and method...
- Patent number 10,940,152
- Issue date Mar 9, 2021
- Signal Pharmaceuticals, LLC
- Matthew Alexander
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antiproliferative compounds and methods of use thereof
- Patent number 10,675,281
- Issue date Jun 9, 2020
- Celgene Corporation
- Matthew D. Alexander
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted aminopurine compounds, compositions thereof, and method...
- Patent number 10,646,493
- Issue date May 12, 2020
- Signal Pharmaceuticals, LLC
- Matthew Alexander
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antiproliferative compounds, and their pharmaceutical compositions...
- Patent number 10,618,883
- Issue date Apr 14, 2020
- Celgene Corporation
- Matthew D. Alexander
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
MK2 inhibitors and uses thereof
- Patent number 10,577,380
- Issue date Mar 3, 2020
- Celgene CAR LLC
- Matthew David Alexander
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted aminopurine compounds, compositions thereof, and method...
- Patent number 10,398,700
- Issue date Sep 3, 2019
- Signal Pharmaceuticals, LLC
- Matthew Alexander
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antiproliferative compounds and methods of use thereof
- Patent number 10,357,489
- Issue date Jul 23, 2019
- Celgene Corporation
- Matthew D. Alexander
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
MK2 inhibitors and uses thereof
- Patent number 10,253,040
- Issue date Apr 9, 2019
- Celgene CAR LLC
- Matthew David Alexander
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antiproliferative compounds, and their pharmaceutical compositions...
- Patent number 10,227,325
- Issue date Mar 12, 2019
- Celgene Corporation
- Matthew D. Alexander
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted aminopurine compounds, compositions thereof, and method...
- Patent number 10,149,849
- Issue date Dec 11, 2018
- Signal Pharmaceuticals, LLC
- Matthew Alexander
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
MK2 inhibitors and uses thereof
- Patent number 10,138,256
- Issue date Nov 27, 2018
- Celgene CAR LLC
- Matthew David Alexander
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antiproliferative compounds, and their pharmaceutical compositions...
- Patent number 9,938,254
- Issue date Apr 10, 2018
- Celgene Corporation
- Matthew D. Alexander
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
MK2 inhibitors and uses thereof
- Patent number 9,790,235
- Issue date Oct 17, 2017
- Celgene CAR LLC
- Matthew David Alexander
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted aminopurine compounds, compositions thereof, and method...
- Patent number 9,737,541
- Issue date Aug 22, 2017
- Signal Pharmaceuticals, LLC
- Matthew Alexander
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted aminopurine compounds, compositions thereof, and method...
- Patent number 9,512,124
- Issue date Dec 6, 2016
- Signal Pharmaceuticals, LLC
- Matthew Alexander
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
MK2 inhibitors and uses thereof
- Patent number 9,458,175
- Issue date Oct 4, 2016
- Celgene Avilomics Research, Inc.
- Matthew David Alexander
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
CEREBLON BINDING COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TR...
- Publication number 20240374591
- Publication date Nov 14, 2024
- Celgene Corporation
- Matthew D. Alexander
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CEREBLON BINDING COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TR...
- Publication number 20240368118
- Publication date Nov 7, 2024
- Celgene Corporation
- Matthew D. Alexander
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TETRAHYDROISOQUINOLINE HETEROBIFUNCTIONAL BCL-XL DEGRADERS
- Publication number 20240238423
- Publication date Jul 18, 2024
- Treeline Biosciences, Inc.
- Evan J. Horn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED 4-AMINOISOINDOLINE-1,3-DIONE COMPOUNDS, COMPOSITIONS TH...
- Publication number 20240217955
- Publication date Jul 4, 2024
- Celgene Corporation
- Matthew D. Alexander
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIPROLIFERATIVE COMPOUNDS AND METHODS OF USE THEREOF
- Publication number 20240207255
- Publication date Jun 27, 2024
- Celgene Corporation
- Matthew D. Alexander
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Modulators of BCL6 as Ligand Directed Degraders
- Publication number 20240025851
- Publication date Jan 25, 2024
- Celgene Corporation
- Dehua Huang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TETRAHYDROISOQUINOLINE HETEROBIFUNCTIONAL BCL-XL DEGRADERS
- Publication number 20230390404
- Publication date Dec 7, 2023
- Treeline Biosciences, Inc.
- Evan J. Horn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CEREBLON BINDING COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TR...
- Publication number 20230348431
- Publication date Nov 2, 2023
- Ceigene Corporation
- Matthew D. Alexander
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CEREBLON BINDING COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TR...
- Publication number 20230242509
- Publication date Aug 3, 2023
- Ceigene Corporation
- Matthew D. Alexander
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED AMINOPURINE COMPOUNDS, COMPOSITIONS THEREOF, AND METHOD...
- Publication number 20230158035
- Publication date May 25, 2023
- Signal Pharmaceuticals, LLC.
- Matthew Alexander
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED 4-AMINOISOINDOLINE-1,3-DIONE COMPOUNDS, COMPOSITIONS TH...
- Publication number 20220306611
- Publication date Sep 29, 2022
- Celgene Corporation
- Matthew D. Alexander
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIPROLIFERATIVE COMPOUNDS AND METHODS OF USE THEREOF
- Publication number 20220280505
- Publication date Sep 8, 2022
- Celgene Corporation
- Matthew D. Alexander
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CEREBLON BINDING COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TR...
- Publication number 20220002273
- Publication date Jan 6, 2022
- Celgene Corporation
- Matthew D. Alexander
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CEREBLON BINDING COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TR...
- Publication number 20210403454
- Publication date Dec 30, 2021
- Celgene Corporation
- Matthew D. Alexander
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CEREBLON BINDING COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TR...
- Publication number 20210403453
- Publication date Dec 30, 2021
- Celgene Corporation
- Matthew D. Alexander
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED AMINOPURINE COMPOUNDS, COMPOSITIONS THEREOF, AND METHOD...
- Publication number 20210128565
- Publication date May 6, 2021
- Signal Pharmaceuticals, LLC.
- Matthew Alexander
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MK2 INHIBITORS AND USES THEREOF
- Publication number 20210053984
- Publication date Feb 25, 2021
- Celgene CAR LLC
- Matthew David Alexander
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIPROLIFERATIVE COMPOUNDS, AND THEIR PHARMACEUTICAL COMPOSITIONS...
- Publication number 20210040063
- Publication date Feb 11, 2021
- Celgene Corporation
- Matthew D. Alexander
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIPROLIFERATIVE COMPOUNDS AND METHODS OF USE THEREOF
- Publication number 20200253964
- Publication date Aug 13, 2020
- Celgene Corporation
- Matthew D. Alexander
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED AMINOPURINE COMPOUNDS, COMPOSITIONS THEREOF, AND METHOD...
- Publication number 20200237768
- Publication date Jul 30, 2020
- Signal Pharmaceuticals, LLC.
- Matthew Alexander
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MK2 INHIBITORS AND USES THEREOF
- Publication number 20190375762
- Publication date Dec 12, 2019
- Celgene CAR LLC
- Matthew David Alexander
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED AMINOPURINE COMPOUNDS, COMPOSITIONS THEREOF, AND METHOD...
- Publication number 20190336507
- Publication date Nov 7, 2019
- Signal Pharmaceuticals, LLC.
- Matthew Alexander
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED 4-AMINOISOINDOLINE-1,3-DIONE COMPOUNDS, COMPOSITIONS TH...
- Publication number 20190322647
- Publication date Oct 24, 2019
- Celgene Corporation
- Matthew D. Alexander
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIPROLIFERATIVE COMPOUNDS AND METHODS OF USE THEREOF
- Publication number 20190282567
- Publication date Sep 19, 2019
- Celgene Corporation
- Matthew D. Alexander
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIPROLIFERATIVE COMPOUNDS, AND THEIR PHARMACEUTICAL COMPOSITIONS...
- Publication number 20190152942
- Publication date May 23, 2019
- Celgene Corporation
- Matthew D. Alexander
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MK2 INHIBITORS AND USES THEREOF
- Publication number 20190135835
- Publication date May 9, 2019
- Celgene CAR LLC
- Matthew David Alexander
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED AMINOPURINE COMPOUNDS, COMPOSITIONS THEREOF, AND METHOD...
- Publication number 20190091230
- Publication date Mar 28, 2019
- Signal Pharmaceuticals, LLC.
- Matthew Alexander
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIPROLIFERATIVE COMPOUNDS AND METHODS OF USE THEREOF
- Publication number 20190008852
- Publication date Jan 10, 2019
- Celgene Corporation
- Matthew D. Alexander
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIPROLIFERATIVE COMPOUNDS, AND THEIR PHARMACEUTICAL COMPOSITIONS...
- Publication number 20180186767
- Publication date Jul 5, 2018
- Celgene Corporation
- Matthew D. Alexander
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED AMINOPURINE COMPOUNDS, COMPOSITIONS THEREOF, AND METHOD...
- Publication number 20170296546
- Publication date Oct 19, 2017
- Signal Pharmaceuticals, LLC.
- Matthew Alexander
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Matthew David ALEXANDER

Person

Patents Grantslast 30 patents

Cereblon binding compounds, compositions thereof, and methods of tr...

Antiproliferative compounds and methods of use thereof

Substituted 4-aminoisoindoline-1,3-dione compounds, compositions th...

Cereblon binding compounds, compositions thereof, and methods of tr...

Cereblon binding compounds, compositions thereof, and methods of tr...

Substituted aminopurine compounds, compositions thereof, and method...

MK2 inhibitors and uses thereof

Cereblon binding compounds, compositions thereof, and methods of tr...

Antiproliferative compounds, and their pharmaceutical compositions...

Substituted 4-aminoisoindoline-1,3-dione compounds, compositions th...

Antiproliferative compounds and methods of use thereof

MK2 inhibitors and uses thereof

Substituted aminopurine compounds, compositions thereof, and method...

Antiproliferative compounds and methods of use thereof

Substituted aminopurine compounds, compositions thereof, and method...

Antiproliferative compounds, and their pharmaceutical compositions...

MK2 inhibitors and uses thereof

Substituted aminopurine compounds, compositions thereof, and method...

Antiproliferative compounds and methods of use thereof

MK2 inhibitors and uses thereof

Antiproliferative compounds, and their pharmaceutical compositions...

Substituted aminopurine compounds, compositions thereof, and method...

MK2 inhibitors and uses thereof

Antiproliferative compounds, and their pharmaceutical compositions...

MK2 inhibitors and uses thereof

Substituted aminopurine compounds, compositions thereof, and method...

Substituted aminopurine compounds, compositions thereof, and method...

MK2 inhibitors and uses thereof

Patents Applicationslast 30 patents

CEREBLON BINDING COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TR...

CEREBLON BINDING COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TR...

TETRAHYDROISOQUINOLINE HETEROBIFUNCTIONAL BCL-XL DEGRADERS

SUBSTITUTED 4-AMINOISOINDOLINE-1,3-DIONE COMPOUNDS, COMPOSITIONS TH...

ANTIPROLIFERATIVE COMPOUNDS AND METHODS OF USE THEREOF

Modulators of BCL6 as Ligand Directed Degraders

TETRAHYDROISOQUINOLINE HETEROBIFUNCTIONAL BCL-XL DEGRADERS

CEREBLON BINDING COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TR...

CEREBLON BINDING COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TR...

SUBSTITUTED AMINOPURINE COMPOUNDS, COMPOSITIONS THEREOF, AND METHOD...

SUBSTITUTED 4-AMINOISOINDOLINE-1,3-DIONE COMPOUNDS, COMPOSITIONS TH...

ANTIPROLIFERATIVE COMPOUNDS AND METHODS OF USE THEREOF

CEREBLON BINDING COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TR...

CEREBLON BINDING COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TR...

CEREBLON BINDING COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TR...

SUBSTITUTED AMINOPURINE COMPOUNDS, COMPOSITIONS THEREOF, AND METHOD...

MK2 INHIBITORS AND USES THEREOF

ANTIPROLIFERATIVE COMPOUNDS, AND THEIR PHARMACEUTICAL COMPOSITIONS...

ANTIPROLIFERATIVE COMPOUNDS AND METHODS OF USE THEREOF

SUBSTITUTED AMINOPURINE COMPOUNDS, COMPOSITIONS THEREOF, AND METHOD...

MK2 INHIBITORS AND USES THEREOF

SUBSTITUTED AMINOPURINE COMPOUNDS, COMPOSITIONS THEREOF, AND METHOD...

SUBSTITUTED 4-AMINOISOINDOLINE-1,3-DIONE COMPOUNDS, COMPOSITIONS TH...

ANTIPROLIFERATIVE COMPOUNDS AND METHODS OF USE THEREOF

ANTIPROLIFERATIVE COMPOUNDS, AND THEIR PHARMACEUTICAL COMPOSITIONS...

MK2 INHIBITORS AND USES THEREOF

SUBSTITUTED AMINOPURINE COMPOUNDS, COMPOSITIONS THEREOF, AND METHOD...

ANTIPROLIFERATIVE COMPOUNDS AND METHODS OF USE THEREOF

ANTIPROLIFERATIVE COMPOUNDS, AND THEIR PHARMACEUTICAL COMPOSITIONS...

SUBSTITUTED AMINOPURINE COMPOUNDS, COMPOSITIONS THEREOF, AND METHOD...